HkRoids
B2CProvides a public, source-linked COA database and maps vendor/listing identifiers to third-party benchmark evidence and test records.
Profile aggregated from Peptigrity — attributed.
Weighted blend of independent signals — Finnrick safety grade, VialAudit blind-buy audit, and Peptigrity HPLC purity. PeptideBenchmark and the Peptigrity trust score are excluded to avoid double-counting. Attributed to its sources — not our verdict.
Independent test grades (4)
Per Finnrick (independent testing). Attributed — Finnrick's grades, not ours.
| Peptide | Grade | Score |
|---|---|---|
| BPC-157 | A | 73.0 |
| Ipamorelin | E | 7.6 |
| GHK-Cu | A | 7.5 |
| Tesamorelin | C Okay | 7.2 |
Independent HPLC tests (40)
Real third-party HPLC results for this vendor, aggregated from Peptigrity and attributed to the lab that ran each test.
| Peptide | HPLC purity | Lab | Date |
|---|---|---|---|
| GHK-Cu | 99.50% | Vanguard Laboratory | 2026-03-03 |
| Retatrutide | 99.45% | Vanguard Laboratory | 2026-03-03 |
| Semaglutide | 99.61% | Vanguard Laboratory | 2026-03-03 |
| GHK-Cu | 99.15% | Vanguard Laboratory | 2026-03-03 |
| CJC-1295 | 99.02% | Vanguard Laboratory | 2026-03-03 |
| BPC-157 |
Other independent ratings
Vendor-level scores from other independent aggregators, shown for cross-reference. Attributed — each source's score, not ours.